2.22
price up icon7.25%   0.15
after-market After Hours: 2.23 0.010 +0.45%
loading
Gain Therapeutics Inc stock is traded at $2.22, with a volume of 191.97K. It is up +7.25% in the last 24 hours and up +21.98% over the past month. Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across, several therapeutics areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. The company derives revenues from collaboration and licensing agreements.
See More
Previous Close:
$2.07
Open:
$2.06
24h Volume:
191.97K
Relative Volume:
0.48
Market Cap:
$57.45M
Revenue:
$210.70K
Net Income/Loss:
$-22.22M
P/E Ratio:
-1.2198
EPS:
-1.82
Net Cash Flow:
$-17.13M
1W Performance:
-13.62%
1M Performance:
+21.98%
6M Performance:
-25.00%
1Y Performance:
-22.65%
1-Day Range:
Value
$2.0201
$2.30
1-Week Range:
Value
$2.0201
$2.58
52-Week Range:
Value
$0.89
$5.33

Gain Therapeutics Inc Stock (GANX) Company Profile

Name
Name
Gain Therapeutics Inc
Name
Phone
(301) 500-1556
Name
Address
4800 HAMPDEN LANE, BETHESDA
Name
Employee
32
Name
Twitter
Name
Next Earnings Date
2024-11-12
Name
Latest SEC Filings
Name
GANX's Discussions on Twitter

Gain Therapeutics Inc Stock (GANX) Upgrades & Downgrades

Date Action Analyst Rating Change
Apr-12-21 Initiated BTIG Research Buy
Apr-12-21 Initiated Oppenheimer Outperform

Gain Therapeutics Inc Stock (GANX) Latest News

pulisher
Nov 01, 2024

2024's 10 Best-Performing Stocks | Investing - U.S News & World Report Money

Nov 01, 2024
pulisher
Nov 01, 2024

Hoping for a weight-loss pill? It could get closer to reality next week. - MarketWatch

Nov 01, 2024
pulisher
Nov 01, 2024

individual investors who own 55% along with institutions invested in Sangamo Therapeutics, Inc. (NASDAQ:SGMO) saw increase in their holdings value last week - Yahoo Finance

Nov 01, 2024
pulisher
Oct 31, 2024

Amneal Pharmaceuticals (NASDAQ:AMRX) grows 3.0% this week, taking five-year gains to 211% - Yahoo Finance

Oct 31, 2024
pulisher
Oct 29, 2024

Short Interest in Gain Therapeutics, Inc. (NASDAQ:GANX) Decreases By 12.6% - MarketBeat

Oct 29, 2024
pulisher
Oct 28, 2024

Vertex Pharmaceuticals (VRTX) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance

Oct 28, 2024
pulisher
Oct 28, 2024

Nuclear stocks gain on AI optimism: Oklo, NuScale, Centrus - Yahoo Finance

Oct 28, 2024
pulisher
Oct 24, 2024

Investing in Arcturus Therapeutics Holdings (NASDAQ:ARCT) five years ago would have delivered you a 76% gain - Yahoo Finance

Oct 24, 2024
pulisher
Oct 23, 2024

Gain Therapeutics Presents Data at 36ᵗʰ EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics Demonstrating Identification of Allosteric Inhibitors Targeting DDR2 - The Manila Times

Oct 23, 2024
pulisher
Oct 23, 2024

What Sangamo Therapeutics, Inc.'s (NASDAQ:SGMO) 26% Share Price Gain Is Not Telling You - Simply Wall St

Oct 23, 2024
pulisher
Oct 21, 2024

Gain Therapeutics Regains Nasdaq Compliance - Investing.com

Oct 21, 2024
pulisher
Oct 21, 2024

Gain Therapeutics Regains Nasdaq Compliance By Investing.com - Investing.com UK

Oct 21, 2024
pulisher
Oct 18, 2024

Viking Therapeutics, Inc. (VKTX) Exceeds Market Returns: Some Facts to Consider - MSN

Oct 18, 2024
pulisher
Oct 18, 2024

32 NMEs gain US FDA clearance through Q3, approvals up over 2023 - BioWorld Online

Oct 18, 2024
pulisher
Oct 16, 2024

Viking Therapeutics, Inc. (VKTX) Outpaces Stock Market Gains: What You Should Know - MSN

Oct 16, 2024
pulisher
Oct 16, 2024

How should investors view Janux Therapeutics Inc (JANX)? - US Post News

Oct 16, 2024
pulisher
Oct 16, 2024

What was Gain Therapeutics Inc (GANX)’s performance in the last session? - US Post News

Oct 16, 2024
pulisher
Oct 15, 2024

Gain Therapeutics Inc [GANX] Investment Guide: What You Need to Know - Knox Daily

Oct 15, 2024
pulisher
Oct 15, 2024

GANX Stock: A Voyage Through Gain Therapeutics Inc’s Finances - The InvestChronicle

Oct 15, 2024
pulisher
Oct 15, 2024

Can you now get a good deal on Compass Therapeutics Inc’s shares? - US Post News

Oct 15, 2024
pulisher
Oct 15, 2024

Gain Therapeutics Announces Poster Presentation at 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics - The Manila Times

Oct 15, 2024
pulisher
Oct 14, 2024

Renaissance Technologies LLC Boosts Holdings in Exagen Inc. (NASDAQ:XGN) - Defense World

Oct 14, 2024
pulisher
Oct 14, 2024

Renaissance Technologies LLC Has $152,000 Stock Position in Gain Therapeutics, Inc. (NASDAQ:GANX) - Defense World

Oct 14, 2024
pulisher
Oct 14, 2024

Investing in Voyager Therapeutics (NASDAQ:VYGR) three years ago would have delivered you a 58% gain - Yahoo Finance

Oct 14, 2024
pulisher
Oct 14, 2024

Boeing, Nurix Therapeutics And 3 Stocks To Watch Heading Into Monday - Benzinga

Oct 14, 2024
pulisher
Oct 10, 2024

Edgewise Therapeutics Inc (EWTX) Stock: Navigating Drops and Gains - The InvestChronicle

Oct 10, 2024
pulisher
Oct 10, 2024

Seres Therapeutics gains amid takeover speculation - Seeking Alpha

Oct 10, 2024
pulisher
Oct 10, 2024

GT-02287 may slow Parkinson’s progression, new early data suggest - Parkinson's News Today

Oct 10, 2024
pulisher
Oct 09, 2024

Soleno Therapeutics Inc [SLNO] Revenue clocked in at $0.00 million, up 29.12% YTD: What’s Next? - The DBT News

Oct 09, 2024
pulisher
Oct 09, 2024

PTC Therapeutics (PTCT) Surges 16.5%: Is This an Indication of Further Gains? - Yahoo

Oct 09, 2024
pulisher
Oct 09, 2024

Gain Therapeutics to Present at Michael J. Fox Foundation's 16th Annual Parkinson's Disease Therapeutics Conference - The Manila Times

Oct 09, 2024
pulisher
Oct 09, 2024

Gain Therapeutics to Present at Michael J. Fox Foundation’s 16th Annual Parkinson’s Disease Therapeutics Conference - Yahoo Finance

Oct 09, 2024
pulisher
Oct 09, 2024

Belite Delights Investors, Soleno, ADMA, Harrow Deliver Triple-digit Gains, Keep An Eye On Oculis - RTTNews

Oct 09, 2024
pulisher
Oct 09, 2024

Gain Therapeutics Announces Positive Preclinical Data for GT-02287 - Defense World

Oct 09, 2024
pulisher
Oct 08, 2024

CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: Here's Why - Yahoo Finance

Oct 08, 2024
pulisher
Oct 08, 2024

Gain Therapeutics Excels in Neurodegenerative Drug Trials - TipRanks

Oct 08, 2024
pulisher
Oct 08, 2024

Gaining Ground: Aptevo Therapeutics Inc (APVO) Closes Lower at 0.16, Down -2.60 - The Dwinnex

Oct 08, 2024
pulisher
Oct 08, 2024

GANX’s Financial Health: Exploring Gain Therapeutics Inc’s Debt-to-Equity Ratio of 1.79 - The InvestChronicle

Oct 08, 2024
pulisher
Oct 08, 2024

Can you still get a good price for Mersana Therapeutics Inc (MRSN) Shares at this point? - US Post News

Oct 08, 2024
pulisher
Oct 08, 2024

Robinhood Markets Inc [HOOD] Stock sold by Insider Gallagher Daniel Martin Jr for $0.28 million - Knox Daily

Oct 08, 2024
pulisher
Oct 08, 2024

GT-02287 shows promise in Parkinson's disease models - Investing.com

Oct 08, 2024
pulisher
Oct 07, 2024

Small-Cap Gain Therapeutics Stock Falls On Phase 1 Data From Its Lead Asset For Parkinson's Disease - MSN

Oct 07, 2024
pulisher
Oct 07, 2024

Three startups aim to raise $400 million as US biotech IPOs gain traction - Yahoo Finance

Oct 07, 2024
pulisher
Oct 07, 2024

Market Insight: Fate Therapeutics Inc (FATE)’s Notable Gain, Closing at 3.22 - The Dwinnex

Oct 07, 2024
pulisher
Oct 07, 2024

Three startups aim to raise $400 mln as US biotech IPOs gain traction - Reuters

Oct 07, 2024
pulisher
Oct 07, 2024

Gaining Ground: Seres Therapeutics Inc (MCRB) Closes Higher at 0.85, Up 1.35 - The Dwinnex

Oct 07, 2024
pulisher
Oct 07, 2024

Gain Therapeutics Presents Preclinical GT-02287 Data at Neuroscience 2024 - The Manila Times

Oct 07, 2024
pulisher
Oct 07, 2024

GT-02287 shows promise in Parkinson's disease models By Investing.com - Investing.com UK

Oct 07, 2024
pulisher
Oct 03, 2024

Can you still get a good price for Denali Therapeutics Inc (DNLI) Shares at this point? - US Post News

Oct 03, 2024
pulisher
Oct 03, 2024

Applied Therapeutics Inc (APLT) Stock: A 52-Week Tale of Drops and Gains - The InvestChronicle

Oct 03, 2024
pulisher
Oct 03, 2024

Gain Therapeutics to Participate at Upcoming Investor Conferences - The Manila Times

Oct 03, 2024

Gain Therapeutics Inc Stock (GANX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Cap:     |  Volume (24h):